Patents by Inventor Matinder KAUR

Matinder KAUR has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • OXOPIPERAZINE DERIVATIVES
    Publication number: 20250115571
    Abstract: The present invention relates to novel compounds of formula (I) or formula (Ia) pharmaceutically-acceptable salts, hydrates, solvates, or stereoisomers thereof, and pharmaceutical compositions of these compounds which are useful for preventive and therapeutic use in human and veterinary medicine.
    Type: Application
    Filed: April 30, 2024
    Publication date: April 10, 2025
    Inventors: Marc LABELLE, Ulrich KESSLER, Valentino CATTORI, Cyril COOK, Ramkrishna Reddy VAKITI, Kevin R. D. JOHNSON, Matinder KAUR, Jean-d'Amour K. TWIBANIRE, Farman ULLAH
  • PYRIDOXAL-5-PHOSPHATE (P5P) ANALOGS
    Publication number: 20250034185
    Abstract: Disclosed are compound, its stereoisomer, salt, hydrate, solvate, isotope or crystalline form thereof, represented by Formula (I), with X, R1, R2, R3, R4 and R5 as disclosed herein. Also, disclosed is a process for their preparation, compositions containing such compounds, methods of medical treatment or prophylaxis of a disease by such compounds and uses thereof. The compounds of Formula (I) are pyridoxal-5-phosphate (P5P) analogs, and can act as prodrugs.
    Type: Application
    Filed: December 15, 2022
    Publication date: January 30, 2025
    Inventors: Albert D. Friesen, Jean-d'amour K. Twibanire, Kevin P. Carlin, Matinder Kaur, Rafiq A. Taj, Syed Mohammed A. Hussani, Vaneet Chehal, Ramkrishna Reddy Vakiti, Bhavin Pipaliya, Cyril Cook, Qasim Khan, Farman Ullah
  • Oxopiperazine derivatives
    Patent number: 12012393
    Abstract: The present invention relates to novel compounds of formula (I) or formula (Ia) pharmaceutically-acceptable salts, hydrates, solvates, or stereoisomers thereof, and pharmaceutical compositions of these compounds which are useful for preventive and therapeutic use in human and veterinary medicine.
    Type: Grant
    Filed: January 7, 2022
    Date of Patent: June 18, 2024
    Assignee: Inthera Bioscience AG
    Inventors: Marc Labelle, Ulrich Kessler, Valentino Cattori, Cyril Cook, Ramkrishna Reddy Vakiti, Kevin R. D. Johnson, Matinder Kaur, Jean-d'amour K. Twibanire, Farman Ullah
  • OXOPIPERAZINE DERIVATIVES
    Publication number: 20220213057
    Abstract: The present invention relates to novel compounds of formula (I) or formula (Ia) pharmaceutically-acceptable salts, hydrates, solvates, or stereoisomers thereof, and pharmaceutical compositions of these compounds which are useful for preventive and therapeutic use in human and veterinary medicine.
    Type: Application
    Filed: January 7, 2022
    Publication date: July 7, 2022
    Inventors: Marc LABELLE, Ulrich KESSLER, Valentino CATTORI, Cyril COOK, Ramkrishna Reddy VAKITI, Kevin R. D. JOHNSON, Matinder KAUR, Jean-d'Amour K. TWIBANIRE, Farman ULLAH
  • Oxopiperazine derivatives
    Patent number: 11306068
    Abstract: The present invention relates to novel compounds of formula (I) or formula (Ia) pharmaceutically-acceptable salts, hydrates, solvates, or stereoisomers thereof, and pharmaceutical compositions of these compounds which are useful for preventive and therapeutic use in human and veterinary medicine.
    Type: Grant
    Filed: June 3, 2020
    Date of Patent: April 19, 2022
    Assignee: Inthera Bioscience AG
    Inventors: Marc Labelle, Ulrich Kessler, Valentino Cattori, Cyril Cook, Ramkrishna Reddy Vakiti, Kevin R. D. Johnson, Matinder Kaur, Jean-d'amour K. Twibanire, Farman Ullah
  • OXOPIPERAZINE DERIVATIVES
    Publication number: 20200308139
    Abstract: The present invention relates to novel compounds of formula (I) or formula (Ia) pharmaceutically-acceptable salts, hydrates, solvates, or stereoisomers thereof, and pharmaceutical compositions of these compounds which are useful for preventive and therapeutic use in human and veterinary medicine.
    Type: Application
    Filed: June 3, 2020
    Publication date: October 1, 2020
    Inventors: Marc LABELLE, Ulrich KESSLER, Valentino CATTORI, Cyril COOK, Ramkrishna Reddy VAKITI, Kevin R. D. JOHNSON, Matinder KAUR, Jean-d'Amour K. TWIBANIRE, Farman ULLAH
  • Oxopiperazine derivatives
    Patent number: 10710975
    Abstract: The present invention relates to novel compounds of formula (I) or formula (Ia) pharmaceutically-acceptable salts, hydrates, solvates, or stereoisomers thereof, and pharmaceutical compositions of these compounds which are useful for preventive and therapeutic use in human and veterinary medicine.
    Type: Grant
    Filed: December 17, 2018
    Date of Patent: July 14, 2020
    Assignee: Inthera Bioscience AG
    Inventors: Marc Labelle, Ulrich Kessler, Valentino Cattori, Cyril Cook, Ramkrishna Reddy Vakiti, Kevin R. D. Johnson, Matinder Kaur, Jean-d'Amour K. Twibanire, Farman Ullah
  • OXOPIPERAZINE DERIVATIVES
    Publication number: 20190185449
    Abstract: The present invention relates to novel compounds of formula (I) or formula (Ia) pharmaceutically-acceptable salts, hydrates, solvates, or stereoisomers thereof, and pharmaceutical compositions of these compounds which are useful for preventive and therapeutic use in human and veterinary medicine.
    Type: Application
    Filed: December 17, 2018
    Publication date: June 20, 2019
    Inventors: Marc LABELLE, Ulrich KESSLER, Valentino CATTORI, Cyril COOK, Ramkrishna Reddy VAKITI, Kevin R. D. JOHNSON, Matinder KAUR, Jean-d'Amour K. TWIBANIRE, Farman ULLAH